El-Halabi M.M.; Zgheib N.; Mansour N.M.; Malli A.; Ghaith O.A.; Mahfouz R.; Alam S.; Sharara A.I.
(PHILADELPHIA530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA, 2013)
The aim of this study is to investigate the effect of CYP2C19 polymorphism and cotherapy with rabeprazole or esomeprazole on the antiplatelet effect of clopidogrel. Patients receiving clopidogrel 75 mg ± rabeprazole or ...